We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Powell Industries
POWL
$7.55B
| $657K | ﹤0.01% |
78,783
+13,134
| +20% | +$130K |
|
2177
MacroGenics
MGNX
$255M
| $656K | ﹤0.01% |
51,665
+16,950
| +49% | +$284K |
|
2178
Option Care Health
OPCH
$3.54B
| $653K | ﹤0.01% |
45,721
+13,919
| +44% | +$184K |
|
2179
Independent Bank Corp
IBCP
$855M
| $652K | ﹤0.01% |
31,000
+9,655
| +45% | +$217K |
|
2180
Peapack-Gladstone Financial
PGC
$815M
| $652K | ﹤0.01% |
25,901
+7,885
| +44% | +$218K |
|
2181
Midland States Bancorp
MSBI
$701M
| $650K | ﹤0.01% |
29,097
+9,974
| +52% | +$260K |
|
|
GMS
2182
DELISTED
GMS Inc
GMS
| $645K | ﹤0.01% |
43,382
+13,816
| +47% | +$243K |
|
|
PLAN
2183
DELISTED
Anaplan, Inc.
PLAN
| $643K | ﹤0.01% |
+24,225
| New | +$599K |
|
|
AGS
2184
DELISTED
PlayAGS
AGS
| $642K | ﹤0.01% |
27,923
+10,952
| +65% | +$260K |
|
2185
GoPro
GPRO
$126M
| $642K | ﹤0.01% |
151,387
+47,755
| +46% | +$267K |
|
2186
Inspire Medical Systems
INSP
$1.7B
| $642K | ﹤0.01% |
15,184
+8,800
| +138% | +$374K |
|
2187
Precigen
PGEN
$2.47B
| $642K | ﹤0.01% |
98,118
+32,785
| +50% | +$367K |
|
|
UCFC
2188
DELISTED
United Community Financial Corp
UCFC
| $639K | ﹤0.01% |
72,181
+20,639
| +40% | +$189K |
|
|
PSDO
2189
DELISTED
Presidio, Inc. Common Stock
PSDO
| $638K | ﹤0.01% |
48,922
+17,559
| +56% | +$243K |
|
2190
Dime Commercial Bancshares
DCOM
$1.81B
| $637K | ﹤0.01% |
24,972
+6,914
| +38% | +$202K |
|
2191
America's Car Mart
CRMT
$27.5M
| $630K | ﹤0.01% |
8,690
+2,662
| +44% | +$196K |
|
2192
Assembly Biosciences
ASMB
$524M
| $628K | ﹤0.01% |
2,312
+800
| +53% | +$231K |
|
|
HTB
2193
HomeTrust Bancshares
HTB
$863M
| $628K | ﹤0.01% |
23,977
+7,358
| +44% | +$196K |
|
|
PDLI
2194
DELISTED
PDL BioPharma, Inc.
PDLI
| $627K | ﹤0.01% |
216,199
+59,953
| +38% | +$165K |
|
2195
Century Communities
CCS
$1.96B
| $626K | ﹤0.01% |
36,253
+11,172
| +45% | +$233K |
|
2196
Financial Institutions
FISI
$827M
| $625K | ﹤0.01% |
24,337
+6,708
| +38% | +$190K |
|
|
APLS
2197
DELISTED
Apellis Pharmaceuticals
APLS
| $620K | ﹤0.01% |
47,040
+15,225
| +48% | +$234K |
|
|
QTNA
2198
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $619K | ﹤0.01% |
43,167
+14,162
| +49% | +$225K |
|
2199
Coherus Oncology
CHRS
$195M
| $618K | ﹤0.01% |
68,251
+24,533
| +56% | +$284K |
|
|
FOCS
2200
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $618K | ﹤0.01% |
23,473
+9,587
| +69% | +$334K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.